Medicines and Healthcare Products Regulatory Agency: Corporate Plan 2023 to 2026 Tom NicholsJuly 6, 2023GVP, pharmacovigilance, MHRA, Patient safetyComment
MHRA Consultation on ICH E6 (R3) Good Clinical Practice (GCP) Guidelines Tom NicholsMay 26, 2023GCP, PHARMACOVIGILANCE CONSULTANCY
MHRA GCP Inspection Metrics Tom NicholsApril 4, 2023pharmacovigilance, GCP, Good Clinical Practice, PHARMACOVIGILANCE CONSULTANCY
PMCPA Social Media Guidance 2023 Tom NicholsFebruary 6, 2023PHARMACOVIGILANCE, PHARMACOVIGILANCE CONSULTANCY, CLINICAL TRIALS, GVP, GCP
CIOMS Glossary of ICH Terms and Definitions Tom NicholsJanuary 24, 2023pharmacovigilance, pharmacovigilance consultancy, clinical trials, GVP, GCP
MHRA updated guidance on pharmacovigilance procedures Tom NicholsNovember 2, 2022PHARMACOVIGILANCE, PHARMACOVIGILANCE CONSULTANCY, CLINICAL TRIALS, GVP, GCP, Pharmacovigilance audit
Publication of CIOMS XI Patient involvement in the development, regulation and safe use of medicines Tom NicholsOctober 14, 2022PHARMACOVIGILANCE, PHARMACOVIGILANCE CONSULTANCY, CLINICAL TRIALS, GVP, GCP, PHARMACOVIGILANCE AUDIT
